Skip to content
MS
unreviewed

LDL receptor (homeostatic uptake, not synthetic enzyme)

0 reactions · 0 pathways

What it does, reaction by reaction

0 reactions

This enzyme appears only in the regulation table, with no catalysed step recorded.

What accelerates and inhibits it

Regulation is pathway-specific, so each context is listed separately

1 entries

Cholesterol Biosynthesis (Mevalonate Pathway)

Accelerated by

SREBP-2 during low cellular cholesterol

Inhibited by

Intracellular cholesterol; PCSK9-mediated receptor degradation

Hormonal control

Insulin can support receptor expression; hepatic sterol status is dominant

Recent literature

No articles returned.